Two potentially functional polymorphisms, rs2297136T > C and rs4143815C > G, in PD-L1 were significantly associated with 1st line paclitaxel-cisplatin chemotherapy response and/or survival in NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.